Home › NDC Lookup › RxCUI directory › RxCUI 261101

Rifapentine 150 MG Oral Tablet [Priftin] — RxCUI 261101

RxNorm drug concept · Semantic branded drug
RxCUI 261101 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI261101
Official nameRifapentine 150 MG Oral Tablet [Priftin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPriftin 150 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)4,737 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rifapentine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • TB bacteria are remarkably adaptable. If you take only one antibiotic, the bacteria can develop resistance to it and the treatment fails. Using rifapentine alongside other TB medic...
  • Why do I have to take rifapentine with other TB medicines — why can't I just take this one?
  • That's actually a very well-known and harmless effect of rifapentine — it turns body fluids red-orange, including urine, sweat, tears, and saliva. It can be startling the first tim...
  • My urine has turned red-orange. Is something wrong?
📖 Read our full Rifapentine guide →

🕸️ Concept Web — How Rifapentine 150 MG Oral Tablet [Priftin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Rifapentine 150 MG Oral Tablet [Priftin] RxCUI 261101

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Rifapentine 35617
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Priftin 262139
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rifapentine Oral Tablet 373786
    • Rifapentine Oral Product 1157431
    • Rifapentine Pill 1157432
    • Rifapentine Oral Tablet [Priftin] 368275
    • Priftin Oral Product 1178235
    • Priftin Pill 1178236
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Rifapentine 150 MG Oral Tablet SCD · 242671
  • Rifapentine 150 MG SCDC · 332427
  • Rifapentine Oral Tablet SCDF · 373786
  • Rifapentine Oral Product SCDG · 1157431
  • Rifapentine Pill SCDG · 1157432

Brand-Name Concepts

  • Rifapentine 150 MG [Priftin] SBDC · 574349
  • Rifapentine Oral Tablet [Priftin] SBDF · 368275
  • Priftin Oral Product SBDG · 1178235
  • Priftin Pill SBDG · 1178236
  • Priftin BN · 262139

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 261101 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00088-2102-24 3 BLISTER PACK in 1 CARTON (0088-2102-24) / 8 TABLET, FILM... Priftin sanofi-aventis U.S. LLC 2017-02-08
Observed labelers: sanofi-aventis U.S. LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$4.8211
Range $4.8211–$4.8211 · middle 50% $4.8211–$4.8211 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.